NEWS
Investival Showcase
November 18th, Skymab is attending Investival Showcase in London
We are eager to explore potential partnerships with investors—let’s schedule a discussion!
Sachs Associates in Basel
September 24, 2024: Skymab is attending the 11th Annual HealthTech Investment Forum (#Sachs_HTIF) and the 24th Annual Biotech in Europe Forum (#Sachs_BEF) in Basel.
We look forward to engaging with the investors community—let’s connect!
North Life Sciences Days
September 18-19, 2024: We’ll be at the North Life Sciences Days. Come discover our most recent innovations and explore partnership opportunities!
ADC Partnering in Boston
September 4-5, 2024: Meet the Skymab team at ADC Partnering in Boston, where we’ll be showcasing our cutting-edge work in ADCs. Don’t miss the chance to connect with us!
AIS Congress in Montpellier
June 20-21, 2024: Skymab will be attending the AIS Congress in Montpellier. Join us to learn more about our latest advancements in ADC development!
World ADC Congress in London
March 12-15, 2024: The Skymab team will be at the World ADC Congress in London. We’re eager to connect with industry leaders—come meet us!
Pfizer Golden Ticket at Paris BioLabs
We’re thrilled to announce that Skymab has been awarded a Pfizer Golden Ticket at Paris BioLabs! This prestigious recognition underscores our innovative work in advancing antibody-drug conjugates (ADCs). We’re excited to leverage this opportunity to further accelerate our research and collaboration efforts. Join us in celebrating this milestone!